share_log

Alliance Global Partners Initiates Coverage On Fortress Biotech With Buy Rating, Announces Price Target of $5

Alliance Global Partners Initiates Coverage On Fortress Biotech With Buy Rating, Announces Price Target of $5

Alliance Global Partners以买入评级启动对丰泽生物技术的报道,宣布目标股价为5美元
Benzinga ·  03/19 08:20

Alliance Global Partners initiates coverage on Fortress Biotech (NASDAQ:FBIO) with a Buy rating and announces Price Target of $5.

Alliance Global Partners开始对丰泽生物科技(纳斯达克股票代码:FBIO)进行报道,评级为买入,并宣布目标股价为5美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发